Moderna Inc. (NASDAQ: MRNA) announced that the New England Journal of Medicine published results from its Phase 3 clinical trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE